<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>The London Longevity Newsletter â€” Issue 06 - Hex Index</title>
  <link rel="stylesheet" href="../../styles.css">
</head>
<body class="reading-mode">
  <header class="reading-header">
    <a href="../../index.html" class="back-link">&larr; Back to Library</a>
  </header>
  <main class="reading-content">
    
    <article class="article-page">
      <header class="article-header">
        <h1>The London Longevity Newsletter â€” Issue 06</h1>
        <div class="article-meta">
          <span class="author">By Various</span>
          <span class="separator">&middot;</span>
          <a href="../../publication/londonlongevity/index.html" class="publication">
            London Longevity Newsletter
          </a>
          <span class="separator">&middot;</span><time>Jul 18, 2025</time>
          <span class="separator">&middot;</span>
          <span class="read-time">3 min read</span>
        </div>
      </header>

      

      <div class="article-excerpt">
        <p>Welcome to Issue 06 of the London Longevity Newsletter ğŸ—ï¸ Today weâ€™re focusing on new longevity biotech research and resources, our upcoming events, and whatâ€™s going on in the market right now âš¡ï¸</p><p><strong>RESEARCH SPOTLIGHT / LONG READ </strong>ğŸ§¬ğŸ€</p><p>Human clinical trial of plasmapheresis effects on biomarkers of aging (efficacy and safety trial) - <a href="https://pubmed.ncbi.nlm.nih.gov/40592961/">Read Here</a> </p><p>A brand new longevity book, <a href="https://www.amazon.co.uk/Hacking-Humanity-Personalised-Predictive-Preventative/dp/075356114X">Hacking Humanity</a> by Lara Lewington has just dropped! Click <a href="https://substack.com/home/post/p-168008884">here</a> to see why Alex Zhavoronkov, the CEO of Insilico Medicine, thinks it can be the longevity medicine genreâ€™s â€œessential translatorâ€ </p><p>What does it take to lead at the intersection of academia, industry, and philanthropy? Learn some about it from <a href="https://www.youtube.com/watch?v=RKrs2jgOLG0">this podcast</a> hosted by Wilbe Stories where they interviewed Bradley Ringeisen, the Executive Director at Innovative Genomics Institute (IGI) </p><p>Want to level-up your biotech industry knowledge and navigate the changing industry with more confidence? Check out <a href="https://racap.thinkific.com/courses/biotechunveiled">this resource</a></p><p>The lifetime accumulation of multimorbidity and its influence on dementia risk: a UK Biobank <a href="https://academic.oup.com/braincomms/article/7/4/fcaf222/8194444">study</a> </p><p>An unbiased comparison of 14 epigenetic clocks in relation to 10-year onset of 174 disease outcomes in 18,859 individuals <a href="https://www.medrxiv.org/content/10.1101/2025.07.14.25331494v1">[pre-print]</a></p><p><strong>MARKET MOMENTUM</strong> ğŸ’¸</p><p>Nvidia is now a $4 trillion company, and there are still no $1 trillion biotech companies. <a href="https://www.living.tech/articles/why-arent-there-any-1-trillion-biotech-companies">Why</a> is that the case? There is still <a href="https://www.linkedin.com/posts/elliot-hershberg_never-ceases-to-blow-my-mind-that-nvda-is-activity-7350600521818263552-fIcd?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAC4iqYgB-FxXiHJUyal9e-DyTiNm_j0OGB0">SO</a> much to do</p><p>Rocheâ€™s Chugai <a href="https://www.biospace.com/business/roches-chugai-breaks-into-aging-via-potential-1b-deal-with-ai-outfit-gero">Breaks</a> Into Aging via Potential $1B+ Deal With AI-driven biotech Gero. The collab will see Chugai creating novel antibody drug candidates using its in-house engineering capabilities</p><p>A new <a href="https://www.linkedin.com/posts/sound-bioventures_a-new-impact-framework-for-investors-in-life-activity-7351521800662507521-Q1Su?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAC4iqYgB-FxXiHJUyal9e-DyTiNm_j0OGB0">impact framework</a> (by Philip Brainin, MD PhD MBA, Associate at Sound Bioventures) for investors in the life sciences: bridging financial returns and patient outcomes. The paper proposes two novel indicators - Science-Adjusted Life Years (SALYs) and Science-Adjusted Disability Years (SADYs)</p><p>Some exciting <a href="https://x.com/shelbynewsad/status/1942665842786697637?s=46&amp;t=NP3LGi6hrUuUjuff5cwvrg">sci-fi/sci-fact</a> longevity (and adjacent) companies you should know </p><p><strong>LONDON LONGEVITY UPCOMING EVENTS </strong>ğŸ§¬ğŸŒƒ</p><p>Our first ever <a href="https://lu.ma/17zi5r0g">Longevity Co-Working Day</a> in London, open for everyone: builders, scientists, and innovators, on Friday, 25th July [spaces are limited] ğŸ‘¥ğŸ§¬ </p><p>Longevity Tuesday: <a href="https://lu.ma/k1w8mg9u">Walk &amp; Talk</a>, on the coming Tuesday, 22nd July ğŸ‘¥ğŸ‘¥</p><p><strong>LONDON ECOSYSTEM HIGHLIGHTS </strong>ğŸŒƒ </p><p>Crick x Cambridge <a href="https://lu.ma/buk83hrw">Innovation Challenge</a> 2025, 21st to 25th July </p><p>100 Female Founders: HealthTech Innovators <a href="https://lu.ma/qjnq3f2d">Meetup</a> at Barclays, 22nd July </p><p><strong>That's a wrap for Issue 06!</strong></p><p>Let us know what you would like to see/hear more of from this newsletter. Reply to this email or leave a comment on Substack!</p><p>See you again in a couple weeks,</p><p><em>Prasasya from London Longevity</em></p><p>Join ...</p>
      </div>

      <div class="read-full-article">
        <a href="https://londonlongevity.substack.com/p/the-london-longevity-newsletter-issue-622" class="read-button" target="_blank" rel="noopener">
          Read full article on London Longevity Newsletter &rarr;
        </a>
        <p class="copyright-note">
          This excerpt is provided for preview purposes.
          Full article content is available on the original publication.
        </p>
      </div>
    </article>
  
  </main>
</body>
</html>